Novartis AG Withdraws Joicela Marketing Application in Europe

Published: Apr 19, 2011

Bloomberg -- Novartis AG (NOVN) withdrew its application to market the Joicela pain pill in the European Union because the Swiss company wasn’t able to provide information to regulators in the time allowed.

Back to news